Syntaxin 1A regulation of weakly inactivating N-type Ca2+ channels.
N- and P/Q-type Ca2+ channels are abundant in nerve terminals where they interact with proteins of the release apparatus, including syntaxin 1A and SNAP-25. In previous studies on N- or P/Q-type Ca2+ channels, syntaxin 1A co-expression reduced current amplitudes, increased voltage-dependent inactivation and/or enhanced G-protein inhibition. However, these studies were conducted in Ca2+ channels that exhibited significant voltage-dependent inactivation. We previously reported that N-type current in bovine chromaffin cells exhibits very little voltage-dependent inactivation and we identified the Ca2+ channel subunits involved. This study was undertaken to determine the effect of syntaxin 1A on this weakly inactivating Ca2+ channel. Co-expression of syntaxin 1A with the weakly inactivating bovine N-type Ca2+ channels in Xenopus oocytes did not appear to alter inactivation but dramatically reduced current amplitudes, without changing cell surface expression. To further understand the mechanisms of syntaxin 1A regulation of this weakly inactivating channel, we examined mutants of the alpha1B subunit, beta2a subunit and syntaxin 1A. We determined that the synprint site of alpha1B and the C-terminal third of syntaxin 1A were necessary for the reduced current amplitude. In addition we show that enhanced G-protein-dependent modulation of the Ca2+ current by syntaxin 1A cannot explain the large suppression of Ca2+ current observed. Of most significance, syntaxin 1A increased voltage-dependent inactivation in channels containing mutant beta2a subunits that cannot be palmitoylated. Our data suggest that changes in inactivation can not explain the reduction in current amplitude produced by co-expressing syntaxin and a weakly inactivating Ca2+ channel.
Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202, USA. johurley@iupui.edu
Joyce H
JH
Hurley
Anne L
AL
Cahill
Meijing
M
Wang
Aaron P
AP
Fox
D000818:Animals; D000954:Antigens, Surface / Q000737:chemistry / Q000235:genetics / Q000494:pharmacology*; D002121:Calcium Channel Blockers / Q000378:metabolism; D020864:Calcium Channels, N-Type / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D002417:Cattle; D004553:Electric Conductivity; D005260:Female; D019204:GTP-Binding Proteins / Q000502:physiology; D009154:Mutation / Q000502:physiology; D009419:Nerve Tissue Proteins / Q000737:chemistry / Q000235:genetics / Q000494:pharmacology*; D009865:Oocytes / Q000187:drug effects / Q000378:metabolism; D020033:Protein Isoforms / Q000235:genetics; D017434:Protein Structure, Tertiary / Q000502:physiology; D051381:Rats; D050827:Syntaxin 1; D014981:Xenopus; D020866:omega-Conotoxin GVIA / Q000378:metabolism
D000954:Antigens, Surface; D002121:Calcium Channel Blockers; D020864:Calcium Channels, N-Type; D009419:Nerve Tissue Proteins; D020033:Protein Isoforms; C494213:Stx1a protein, rat; D050827:Syntaxin 1; D020866:omega-Conotoxin GVIA; D019204:GTP-Binding Proteins